Show
Sort by
-
- Journal Article
- A1
- open access
Diagnosis and monitoring denosumab therapy of giant cell tumors of bone : radiologic-pathologic correlation
-
- Journal Article
- A1
- open access
RANKL blockade for erosive hand osteoarthritis : a randomized placebo-controlled phase 2a trial
-
Imaging findings and value of CT and DCE-MRI in monitoring denosumab therapy of giant cell tumors of bone
(2022) SEMINARS IN MUSCULOSKELETAL RADIOLOGY. In Seminars in Musculoskeletal Radiology 26(3). p.361-384 -
- Journal Article
- A1
- open access
Bone health and therapeutic agents in advanced prostate cancer
-
- Conference Paper
- C3
- open access
Imaging findings and value of CT and (DCE-)MRI in monitoring denosumab therapy of giant cell tumors of bone
-
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials
-
- Conference Paper
- C3
- open access
Longitudinal CT and MR evaluation of denosumab therapy in giant cell tumours of bone
-
- Journal Article
- A1
- open access
Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis
-
- Journal Article
- A1
- open access
Effects of 24 months of treatment with romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density : a randomized, double-blind, phase 2, parallel group study
-
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy : a randomised, open-label, phase 3 trial